209 related articles for article (PubMed ID: 30895415)
1. Global patterns and trends in the incidence of non-Hodgkin lymphoma.
Miranda-Filho A; Piñeros M; Znaor A; Marcos-Gragera R; Steliarova-Foucher E; Bray F
Cancer Causes Control; 2019 May; 30(5):489-499. PubMed ID: 30895415
[TBL] [Abstract][Full Text] [Related]
2. Global patterns of non-Hodgkin lymphoma in 2020.
Mafra A; Laversanne M; Gospodarowicz M; Klinger P; De Paula Silva N; Piñeros M; Steliarova-Foucher E; Bray F; Znaor A
Int J Cancer; 2022 Nov; 151(9):1474-1481. PubMed ID: 35695282
[TBL] [Abstract][Full Text] [Related]
3. Global burden, risk factors, and trends of non-Hodgkin lymphoma: A worldwide analysis of cancer registries.
Huang J; Chan SC; Lok V; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Elcarte E; Withers M; Wong MCS
Cancer Med; 2024 Mar; 13(5):e7056. PubMed ID: 38477498
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin lymphoma risk in adults living with HIV across five continents.
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord
AIDS; 2018 Nov; 32(18):2777-2786. PubMed ID: 30234606
[TBL] [Abstract][Full Text] [Related]
6. The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends.
Chu Y; Liu Y; Fang X; Jiang Y; Ding M; Ge X; Yuan D; Lu K; Li P; Li Y; Xu H; Fan J; Zhou X; Wang X
Front Oncol; 2023; 13():1059914. PubMed ID: 37333805
[TBL] [Abstract][Full Text] [Related]
7. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
8. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
9. Incidence and mortality from non-Hodgkin lymphoma in Europe: the end of an epidemic?
Bosetti C; Levi F; Ferlay J; Lucchini F; Negri E; La Vecchia C
Int J Cancer; 2008 Oct; 123(8):1917-23. PubMed ID: 18688859
[TBL] [Abstract][Full Text] [Related]
10. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences.
Wu XC; Andrews P; Chen VW; Groves FD
Cancer Epidemiol; 2009 Nov; 33(5):337-46. PubMed ID: 19853554
[TBL] [Abstract][Full Text] [Related]
11. Changing incidence of non-Hodgkin lymphomas in the United States.
Clarke CA; Glaser SL
Cancer; 2002 Apr; 94(7):2015-23. PubMed ID: 11932904
[TBL] [Abstract][Full Text] [Related]
12. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population.
Howell JM; Auer-Grzesiak I; Zhang J; Andrews CN; Stewart D; Urbanski SJ
Can J Gastroenterol; 2012 Jul; 26(7):452-6. PubMed ID: 22803021
[TBL] [Abstract][Full Text] [Related]
13. The burden of non-Hodgkin lymphoma in Central and South America.
Diumenjo MC; Abriata G; Forman D; Sierra MS
Cancer Epidemiol; 2016 Sep; 44 Suppl 1():S168-S177. PubMed ID: 27678319
[TBL] [Abstract][Full Text] [Related]
14. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995.
Groves FD; Linet MS; Travis LB; Devesa SS
J Natl Cancer Inst; 2000 Aug; 92(15):1240-51. PubMed ID: 10922409
[TBL] [Abstract][Full Text] [Related]
15. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.
Singh D; Vignat J; Lorenzoni V; Eslahi M; Ginsburg O; Lauby-Secretan B; Arbyn M; Basu P; Bray F; Vaccarella S
Lancet Glob Health; 2023 Feb; 11(2):e197-e206. PubMed ID: 36528031
[TBL] [Abstract][Full Text] [Related]
16. Increasing incidence of non-Hodgkin's lymphoma in Karachi, 1995-2002.
Bhurgri Y; Pervez S; Bhurgri A; Faridi N; Usman A; Kazi LA; Ahmed R; Kayani N; Hasan SH
Asian Pac J Cancer Prev; 2005; 6(3):364-9. PubMed ID: 16236001
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988.
Zheng T; Mayne ST; Boyle P; Holford TR; Liu WL; Flannery J
Cancer; 1992 Aug; 70(4):840-9. PubMed ID: 1643616
[TBL] [Abstract][Full Text] [Related]
18. Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017.
Sun H; Xue L; Guo Y; Du J; Nan K; Li M
Ann Med; 2022 Dec; 54(1):633-645. PubMed ID: 35196922
[TBL] [Abstract][Full Text] [Related]
19. Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.
Sandin S; Hjalgrim H; Glimelius B; Rostgaard K; Pukkala E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1295-300. PubMed ID: 16835326
[TBL] [Abstract][Full Text] [Related]
20. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years.
Linet MS; Brown LM; Mbulaiteye SM; Check D; Ostroumova E; Landgren A; Devesa SS
Int J Cancer; 2016 Apr; 138(8):1862-74. PubMed ID: 26562742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
